APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Synthesis and Radiolabeling

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Synthesis and Radiolabeling Market Outlook and Growth Opportunities 2026

3 March 2026218 pages

Choose your research edition.

Industry ResearchCustom Synthesis and Radiolabeling Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Synthesis and Radiolabeling Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Custom Synthesis and Radiolabeling Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Synthesis and Radiolabeling Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Synthesis and Radiolabeling Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Custom Synthesis and Radiolabeling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Synthesis and Radiolabeling market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Synthesis and Radiolabeling market include Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences and Gifford Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Synthesis and Radiolabeling market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Synthesis and Radiolabeling and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Synthesis and Radiolabeling revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Synthesis and Radiolabeling market.

Custom Synthesis and Radiolabeling Segment by Company

Charles River

Eurofins Scientific

PerkinElmer

Sekisui Medical

Eckert & Ziegler

Labcorp

XenoTech (BioIVT)

Quotient Sciences

Gifford Bioscience

ITM Radiopharma

Almac Group

Accelera

Novandi Chemistry

AptoChem

HMR

AM Chemicals

PolyPeptide Group

NovoPro Bioscience

Institute of Isotopes

Nuvisan

Revvity

Necsa

Fluorizon

Edinburgh Pharmaceutical Processes

Chelatec

Pharmaron

Medicilon

JOINN Laboratories

Frontage

Abace Biotechnology

Beijing Atom High-Tech

Wuxi Beita Pharmatech

Beijing North Institute of Biotechnology

Custom Synthesis and Radiolabeling Segment by Type

C-14

H-3

I-125

Others

Custom Synthesis and Radiolabeling Segment by Application

Drug Discovery

Medical

Others

Custom Synthesis and Radiolabeling Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Synthesis and Radiolabeling status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Synthesis and Radiolabeling key companies, revenue, market share, and recent developments.

3. To split the Custom Synthesis and Radiolabeling breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Synthesis and Radiolabeling market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Synthesis and Radiolabeling significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Synthesis and Radiolabeling competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthesis and Radiolabeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Synthesis and Radiolabeling and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthesis and Radiolabeling.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Synthesis and Radiolabeling industry.

Chapter 3: Detailed analysis of Custom Synthesis and Radiolabeling company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Synthesis and Radiolabeling in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Synthesis and Radiolabeling in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Synthesis and Radiolabeling Industry Trends Table 2. Custom Synthesis and Radiolabeling Industry Drivers Table 3. Custom Synthesis and Radiolabeling Industry Opportunities and Challenges Table 4. Custom Synthesis and Radiolabeling Industry Restraints Table 5. Global Custom Synthesis and Radiolabeling Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Synthesis and Radiolabeling Revenue Share by Company (2021-2026) Table 7. Global Custom Synthesis and Radiolabeling Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Synthesis and Radiolabeling Key Company Manufacturing Base & Headquarters Table 9. Global Custom Synthesis and Radiolabeling Company, Product Type & Application Table 10. Global Custom Synthesis and Radiolabeling Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Synthesis and Radiolabeling by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of C-14 Table 15. Significant Companies of H-3 Table 16. Significant Companies of I-125 Table 17. Significant Companies of Others Table 18. Global Custom Synthesis and Radiolabeling Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Custom Synthesis and Radiolabeling Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Custom Synthesis and Radiolabeling Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Custom Synthesis and Radiolabeling Sales Value Share by Type (2021-2026) Table 22. Global Custom Synthesis and Radiolabeling Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Drug Discovery Table 24. Significant Companies of Medical Table 25. Significant Companies of Others Table 26. Global Custom Synthesis and Radiolabeling Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Custom Synthesis and Radiolabeling Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Custom Synthesis and Radiolabeling Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Custom Synthesis and Radiolabeling Sales Value Share by Application (2021-2026) Table 30. Global Custom Synthesis and Radiolabeling Sales Value Share by Application (2027-2032) Table 31. Global Custom Synthesis and Radiolabeling Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Custom Synthesis and Radiolabeling Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Custom Synthesis and Radiolabeling Sales Value Share by Region (2021-2026) Table 34. Global Custom Synthesis and Radiolabeling Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Custom Synthesis and Radiolabeling Sales Value Share by Region (2027-2032) Table 36. Global Custom Synthesis and Radiolabeling Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Custom Synthesis and Radiolabeling Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Custom Synthesis and Radiolabeling Sales Value Market Share by Country (2021-2026) Table 39. Global Custom Synthesis and Radiolabeling Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Custom Synthesis and Radiolabeling Sales Value Market Share by Country (2027-2032) Table 41. Charles River Company Information Table 42. Charles River Business Overview Table 43. Charles River Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Charles River Custom Synthesis and Radiolabeling Product Portfolio Table 45. Charles River Recent Development Table 46. Eurofins Scientific Company Information Table 47. Eurofins Scientific Business Overview Table 48. Eurofins Scientific Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio Table 50. Eurofins Scientific Recent Development Table 51. PerkinElmer Company Information Table 52. PerkinElmer Business Overview Table 53. PerkinElmer Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio Table 55. PerkinElmer Recent Development Table 56. Sekisui Medical Company Information Table 57. Sekisui Medical Business Overview Table 58. Sekisui Medical Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio Table 60. Sekisui Medical Recent Development Table 61. Eckert & Ziegler Company Information Table 62. Eckert & Ziegler Business Overview Table 63. Eckert & Ziegler Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio Table 65. Eckert & Ziegler Recent Development Table 66. Labcorp Company Information Table 67. Labcorp Business Overview Table 68. Labcorp Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Labcorp Custom Synthesis and Radiolabeling Product Portfolio Table 70. Labcorp Recent Development Table 71. XenoTech (BioIVT) Company Information Table 72. XenoTech (BioIVT) Business Overview Table 73. XenoTech (BioIVT) Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio Table 75. XenoTech (BioIVT) Recent Development Table 76. Quotient Sciences Company Information Table 77. Quotient Sciences Business Overview Table 78. Quotient Sciences Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio Table 80. Quotient Sciences Recent Development Table 81. Gifford Bioscience Company Information Table 82. Gifford Bioscience Business Overview Table 83. Gifford Bioscience Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio Table 85. Gifford Bioscience Recent Development Table 86. ITM Radiopharma Company Information Table 87. ITM Radiopharma Business Overview Table 88. ITM Radiopharma Custom Synthesis and Radiolabeling Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio Table 90. ITM Radiopharma Recent Development Table 91. Almac Group Company Information Table 92. Almac Group Business Overview Table 93. Almac Group Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Almac Group Custom Synthesis and Radiolabeling Product Portfolio Table 95. Almac Group Recent Development Table 96. Accelera Company Information Table 97. Accelera Business Overview Table 98. Accelera Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Accelera Custom Synthesis and Radiolabeling Product Portfolio Table 100. Accelera Recent Development Table 101. Novandi Chemistry Company Information Table 102. Novandi Chemistry Business Overview Table 103. Novandi Chemistry Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio Table 105. Novandi Chemistry Recent Development Table 106. AptoChem Company Information Table 107. AptoChem Business Overview Table 108. AptoChem Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. AptoChem Custom Synthesis and Radiolabeling Product Portfolio Table 110. AptoChem Recent Development Table 111. HMR Company Information Table 112. HMR Business Overview Table 113. HMR Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. HMR Custom Synthesis and Radiolabeling Product Portfolio Table 115. HMR Recent Development Table 116. AM Chemicals Company Information Table 117. AM Chemicals Business Overview Table 118. AM Chemicals Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio Table 120. AM Chemicals Recent Development Table 121. PolyPeptide Group Company Information Table 122. PolyPeptide Group Business Overview Table 123. PolyPeptide Group Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio Table 125. PolyPeptide Group Recent Development Table 126. NovoPro Bioscience Company Information Table 127. NovoPro Bioscience Business Overview Table 128. NovoPro Bioscience Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio Table 130. NovoPro Bioscience Recent Development Table 131. Institute of Isotopes Company Information Table 132. Institute of Isotopes Business Overview Table 133. Institute of Isotopes Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio Table 135. Institute of Isotopes Recent Development Table 136. Nuvisan Company Information Table 137. Nuvisan Business Overview Table 138. Nuvisan Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Nuvisan Custom Synthesis and Radiolabeling Product Portfolio Table 140. Nuvisan Recent Development Table 141. Revvity Company Information Table 142. Revvity Business Overview Table 143. Revvity Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Revvity Custom Synthesis and Radiolabeling Product Portfolio Table 145. Revvity Recent Development Table 146. Necsa Company Information Table 147. Necsa Business Overview Table 148. Necsa Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Necsa Custom Synthesis and Radiolabeling Product Portfolio Table 150. Necsa Recent Development Table 151. Fluorizon Company Information Table 152. Fluorizon Business Overview Table 153. Fluorizon Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Fluorizon Custom Synthesis and Radiolabeling Product Portfolio Table 155. Fluorizon Recent Development Table 156. Edinburgh Pharmaceutical Processes Company Information Table 157. Edinburgh Pharmaceutical Processes Business Overview Table 158. Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio Table 160. Edinburgh Pharmaceutical Processes Recent Development Table 161. Chelatec Company Information Table 162. Chelatec Business Overview Table 163. Chelatec Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Chelatec Custom Synthesis and Radiolabeling Product Portfolio Table 165. Chelatec Recent Development Table 166. Pharmaron Company Information Table 167. Pharmaron Business Overview Table 168. Pharmaron Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Pharmaron Custom Synthesis and Radiolabeling Product Portfolio Table 170. Pharmaron Recent Development Table 171. Medicilon Company Information Table 172. Medicilon Business Overview Table 173. Medicilon Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Medicilon Custom Synthesis and Radiolabeling Product Portfolio Table 175. Medicilon Recent Development Table 176. JOINN Laboratories Company Information Table 177. JOINN Laboratories Business Overview Table 178. JOINN Laboratories Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio Table 180. JOINN Laboratories Recent Development Table 181. Frontage Company Information Table 182. Frontage Business Overview Table 183. Frontage Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Frontage Custom Synthesis and Radiolabeling Product Portfolio Table 185. Frontage Recent Development Table 186. Abace Biotechnology Company Information Table 187. Abace Biotechnology Business Overview Table 188. Abace Biotechnology Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio Table 190. Abace Biotechnology Recent Development Table 191. Beijing Atom High-Tech Company Information Table 192. Beijing Atom High-Tech Business Overview Table 193. Beijing Atom High-Tech Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio Table 195. Beijing Atom High-Tech Recent Development Table 196. Wuxi Beita Pharmatech Company Information Table 197. Wuxi Beita Pharmatech Business Overview Table 198. Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio Table 200. Wuxi Beita Pharmatech Recent Development Table 201. Beijing North Institute of Biotechnology Company Information Table 202. Beijing North Institute of Biotechnology Business Overview Table 203. Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio Table 205. Beijing North Institute of Biotechnology Recent Development Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Custom Synthesis and Radiolabeling Product Image Figure 2. Global Custom Synthesis and Radiolabeling Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Synthesis and Radiolabeling Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Synthesis and Radiolabeling Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. C-14 Image Figure 8. H-3 Image Figure 9. I-125 Image Figure 10. Others Image Figure 11. Global Custom Synthesis and Radiolabeling Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Custom Synthesis and Radiolabeling Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Custom Synthesis and Radiolabeling Sales Value Share by Type (2021-2032) Figure 14. Drug Discovery Image Figure 15. Medical Image Figure 16. Others Image Figure 17. Global Custom Synthesis and Radiolabeling Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Custom Synthesis and Radiolabeling Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Custom Synthesis and Radiolabeling Sales Value Share by Application (2021-2032) Figure 20. Global Custom Synthesis and Radiolabeling Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Custom Synthesis and Radiolabeling Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Custom Synthesis and Radiolabeling Sales Value (2021-2032) & (US$ Million) Figure 23. North America Custom Synthesis and Radiolabeling Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Custom Synthesis and Radiolabeling Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Custom Synthesis and Radiolabeling Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Custom Synthesis and Radiolabeling Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Custom Synthesis and Radiolabeling Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Custom Synthesis and Radiolabeling Sales Value (2021-2032) & (US$ Million) Figure 29. South America Custom Synthesis and Radiolabeling Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Custom Synthesis and Radiolabeling Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Custom Synthesis and Radiolabeling Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • C-14
  • H-3
  • I-125
  • Others
Applications
  • Drug Discovery
  • Medical
  • Others
Companies covered
  • Charles River
  • Eurofins Scientific
  • PerkinElmer
  • Sekisui Medical
  • Eckert & Ziegler
  • Labcorp
  • XenoTech (BioIVT)
  • Quotient Sciences
  • Gifford Bioscience
  • ITM Radiopharma
  • Almac Group
  • Accelera
  • Novandi Chemistry
  • AptoChem
  • HMR
  • AM Chemicals
  • PolyPeptide Group
  • NovoPro Bioscience
  • Institute of Isotopes
  • Nuvisan
  • Revvity
  • Necsa
  • Fluorizon
  • Edinburgh Pharmaceutical Processes
  • Chelatec
  • Pharmaron
  • Medicilon
  • JOINN Laboratories
  • Frontage
  • Abace Biotechnology
  • Beijing Atom High-Tech
  • Wuxi Beita Pharmatech
  • Beijing North Institute of Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Synthesis and Radiolabeling Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Synthesis and Radiolabeling Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Synthesis and Radiolabeling Market Dynamics
  1. 2.1 Custom Synthesis and Radiolabeling Industry Trends
  2. 2.2 Custom Synthesis and Radiolabeling Industry Drivers
  3. 2.3 Custom Synthesis and Radiolabeling Industry Opportunities and Challenges
  4. 2.4 Custom Synthesis and Radiolabeling Industry Restraints
3 Custom Synthesis and Radiolabeling Market by Company
  1. 3.1 Global Custom Synthesis and Radiolabeling Company Revenue Ranking in 2025
  2. 3.2 Global Custom Synthesis and Radiolabeling Revenue by Company (2021-2026)
  3. 3.3 Global Custom Synthesis and Radiolabeling Company Ranking (2024-2026)
  4. 3.4 Global Custom Synthesis and Radiolabeling Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Synthesis and Radiolabeling Company Product Type and Application
  6. 3.6 Global Custom Synthesis and Radiolabeling Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Synthesis and Radiolabeling Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Synthesis and Radiolabeling Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Synthesis and Radiolabeling Market by Type
  1. 4.1 Custom Synthesis and Radiolabeling Type Introduction
  2. 4.1.1 C-14
  3. 4.1.2 H-3
  4. 4.1.3 I-125
  5. 4.1.4 Others
  6. 4.2 Global Custom Synthesis and Radiolabeling Sales Value by Type
  7. 4.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Type (2021-2032)
  9. 4.2.3 Global Custom Synthesis and Radiolabeling Sales Value Share by Type (2021-2032)
5 Custom Synthesis and Radiolabeling Market by Application
  1. 5.1 Custom Synthesis and Radiolabeling Application Introduction
  2. 5.1.1 Drug Discovery
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Custom Synthesis and Radiolabeling Sales Value by Application
  6. 5.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Application (2021-2032)
  8. 5.2.3 Global Custom Synthesis and Radiolabeling Sales Value Share by Application (2021-2032)
6 Custom Synthesis and Radiolabeling Regional Value Analysis
  1. 6.1 Global Custom Synthesis and Radiolabeling Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Synthesis and Radiolabeling Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Synthesis and Radiolabeling Sales Value (2021-2032)
  7. 6.3.2 North America Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Synthesis and Radiolabeling Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Synthesis and Radiolabeling Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Synthesis and Radiolabeling Sales Value (2021-2032)
  16. 6.6.2 South America Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Synthesis and Radiolabeling Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Synthesis and Radiolabeling Sales Value Share by Country, 2025 VS 2032
7 Custom Synthesis and Radiolabeling Country-level Value Analysis
  1. 7.1 Global Custom Synthesis and Radiolabeling Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Synthesis and Radiolabeling Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Synthesis and Radiolabeling Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Synthesis and Radiolabeling Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Synthesis and Radiolabeling Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Synthesis and Radiolabeling Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Synthesis and Radiolabeling Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Custom Synthesis and Radiolabeling Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Eurofins Scientific
  8. 8.2.1 Eurofins Scientific Company Information
  9. 8.2.2 Eurofins Scientific Business Overview
  10. 8.2.3 Eurofins Scientific Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
  12. 8.2.5 Eurofins Scientific Recent Developments
  13. 8.3 PerkinElmer
  14. 8.3.1 PerkinElmer Company Information
  15. 8.3.2 PerkinElmer Business Overview
  16. 8.3.3 PerkinElmer Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
  18. 8.3.5 PerkinElmer Recent Developments
  19. 8.4 Sekisui Medical
  20. 8.4.1 Sekisui Medical Company Information
  21. 8.4.2 Sekisui Medical Business Overview
  22. 8.4.3 Sekisui Medical Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
  24. 8.4.5 Sekisui Medical Recent Developments
  25. 8.5 Eckert & Ziegler
  26. 8.5.1 Eckert & Ziegler Company Information
  27. 8.5.2 Eckert & Ziegler Business Overview
  28. 8.5.3 Eckert & Ziegler Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
  30. 8.5.5 Eckert & Ziegler Recent Developments
  31. 8.6 Labcorp
  32. 8.6.1 Labcorp Company Information
  33. 8.6.2 Labcorp Business Overview
  34. 8.6.3 Labcorp Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labcorp Custom Synthesis and Radiolabeling Product Portfolio
  36. 8.6.5 Labcorp Recent Developments
  37. 8.7 XenoTech (BioIVT)
  38. 8.7.1 XenoTech (BioIVT) Company Information
  39. 8.7.2 XenoTech (BioIVT) Business Overview
  40. 8.7.3 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  41. 8.7.4 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
  42. 8.7.5 XenoTech (BioIVT) Recent Developments
  43. 8.8 Quotient Sciences
  44. 8.8.1 Quotient Sciences Company Information
  45. 8.8.2 Quotient Sciences Business Overview
  46. 8.8.3 Quotient Sciences Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
  48. 8.8.5 Quotient Sciences Recent Developments
  49. 8.9 Gifford Bioscience
  50. 8.9.1 Gifford Bioscience Company Information
  51. 8.9.2 Gifford Bioscience Business Overview
  52. 8.9.3 Gifford Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
  54. 8.9.5 Gifford Bioscience Recent Developments
  55. 8.10 ITM Radiopharma
  56. 8.10.1 ITM Radiopharma Company Information
  57. 8.10.2 ITM Radiopharma Business Overview
  58. 8.10.3 ITM Radiopharma Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
  60. 8.10.5 ITM Radiopharma Recent Developments
  61. 8.11 Almac Group
  62. 8.11.1 Almac Group Company Information
  63. 8.11.2 Almac Group Business Overview
  64. 8.11.3 Almac Group Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Almac Group Custom Synthesis and Radiolabeling Product Portfolio
  66. 8.11.5 Almac Group Recent Developments
  67. 8.12 Accelera
  68. 8.12.1 Accelera Company Information
  69. 8.12.2 Accelera Business Overview
  70. 8.12.3 Accelera Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Accelera Custom Synthesis and Radiolabeling Product Portfolio
  72. 8.12.5 Accelera Recent Developments
  73. 8.13 Novandi Chemistry
  74. 8.13.1 Novandi Chemistry Company Information
  75. 8.13.2 Novandi Chemistry Business Overview
  76. 8.13.3 Novandi Chemistry Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
  78. 8.13.5 Novandi Chemistry Recent Developments
  79. 8.14 AptoChem
  80. 8.14.1 AptoChem Company Information
  81. 8.14.2 AptoChem Business Overview
  82. 8.14.3 AptoChem Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AptoChem Custom Synthesis and Radiolabeling Product Portfolio
  84. 8.14.5 AptoChem Recent Developments
  85. 8.15 HMR
  86. 8.15.1 HMR Company Information
  87. 8.15.2 HMR Business Overview
  88. 8.15.3 HMR Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  89. 8.15.4 HMR Custom Synthesis and Radiolabeling Product Portfolio
  90. 8.15.5 HMR Recent Developments
  91. 8.16 AM Chemicals
  92. 8.16.1 AM Chemicals Company Information
  93. 8.16.2 AM Chemicals Business Overview
  94. 8.16.3 AM Chemicals Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
  96. 8.16.5 AM Chemicals Recent Developments
  97. 8.17 PolyPeptide Group
  98. 8.17.1 PolyPeptide Group Company Information
  99. 8.17.2 PolyPeptide Group Business Overview
  100. 8.17.3 PolyPeptide Group Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  101. 8.17.4 PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
  102. 8.17.5 PolyPeptide Group Recent Developments
  103. 8.18 NovoPro Bioscience
  104. 8.18.1 NovoPro Bioscience Company Information
  105. 8.18.2 NovoPro Bioscience Business Overview
  106. 8.18.3 NovoPro Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  107. 8.18.4 NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
  108. 8.18.5 NovoPro Bioscience Recent Developments
  109. 8.19 Institute of Isotopes
  110. 8.19.1 Institute of Isotopes Company Information
  111. 8.19.2 Institute of Isotopes Business Overview
  112. 8.19.3 Institute of Isotopes Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
  114. 8.19.5 Institute of Isotopes Recent Developments
  115. 8.20 Nuvisan
  116. 8.20.1 Nuvisan Company Information
  117. 8.20.2 Nuvisan Business Overview
  118. 8.20.3 Nuvisan Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
  120. 8.20.5 Nuvisan Recent Developments
  121. 8.21 Revvity
  122. 8.21.1 Revvity Company Information
  123. 8.21.2 Revvity Business Overview
  124. 8.21.3 Revvity Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Revvity Custom Synthesis and Radiolabeling Product Portfolio
  126. 8.21.5 Revvity Recent Developments
  127. 8.22 Necsa
  128. 8.22.1 Necsa Company Information
  129. 8.22.2 Necsa Business Overview
  130. 8.22.3 Necsa Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Necsa Custom Synthesis and Radiolabeling Product Portfolio
  132. 8.22.5 Necsa Recent Developments
  133. 8.23 Fluorizon
  134. 8.23.1 Fluorizon Company Information
  135. 8.23.2 Fluorizon Business Overview
  136. 8.23.3 Fluorizon Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
  138. 8.23.5 Fluorizon Recent Developments
  139. 8.24 Edinburgh Pharmaceutical Processes
  140. 8.24.1 Edinburgh Pharmaceutical Processes Company Information
  141. 8.24.2 Edinburgh Pharmaceutical Processes Business Overview
  142. 8.24.3 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
  144. 8.24.5 Edinburgh Pharmaceutical Processes Recent Developments
  145. 8.25 Chelatec
  146. 8.25.1 Chelatec Company Information
  147. 8.25.2 Chelatec Business Overview
  148. 8.25.3 Chelatec Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Chelatec Custom Synthesis and Radiolabeling Product Portfolio
  150. 8.25.5 Chelatec Recent Developments
  151. 8.26 Pharmaron
  152. 8.26.1 Pharmaron Company Information
  153. 8.26.2 Pharmaron Business Overview
  154. 8.26.3 Pharmaron Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
  156. 8.26.5 Pharmaron Recent Developments
  157. 8.27 Medicilon
  158. 8.27.1 Medicilon Company Information
  159. 8.27.2 Medicilon Business Overview
  160. 8.27.3 Medicilon Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Medicilon Custom Synthesis and Radiolabeling Product Portfolio
  162. 8.27.5 Medicilon Recent Developments
  163. 8.28 JOINN Laboratories
  164. 8.28.1 JOINN Laboratories Company Information
  165. 8.28.2 JOINN Laboratories Business Overview
  166. 8.28.3 JOINN Laboratories Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  167. 8.28.4 JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
  168. 8.28.5 JOINN Laboratories Recent Developments
  169. 8.29 Frontage
  170. 8.29.1 Frontage Company Information
  171. 8.29.2 Frontage Business Overview
  172. 8.29.3 Frontage Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Frontage Custom Synthesis and Radiolabeling Product Portfolio
  174. 8.29.5 Frontage Recent Developments
  175. 8.30 Abace Biotechnology
  176. 8.30.1 Abace Biotechnology Company Information
  177. 8.30.2 Abace Biotechnology Business Overview
  178. 8.30.3 Abace Biotechnology Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
  180. 8.30.5 Abace Biotechnology Recent Developments
  181. 8.31 Beijing Atom High-Tech
  182. 8.31.1 Beijing Atom High-Tech Company Information
  183. 8.31.2 Beijing Atom High-Tech Business Overview
  184. 8.31.3 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
  186. 8.31.5 Beijing Atom High-Tech Recent Developments
  187. 8.32 Wuxi Beita Pharmatech
  188. 8.32.1 Wuxi Beita Pharmatech Company Information
  189. 8.32.2 Wuxi Beita Pharmatech Business Overview
  190. 8.32.3 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  191. 8.32.4 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
  192. 8.32.5 Wuxi Beita Pharmatech Recent Developments
  193. 8.33 Beijing North Institute of Biotechnology
  194. 8.33.1 Beijing North Institute of Biotechnology Company Information
  195. 8.33.2 Beijing North Institute of Biotechnology Business Overview
  196. 8.33.3 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
  198. 8.33.5 Beijing North Institute of Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst